Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 10/2009

01-10-2009 | Clinical Correspondence

Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication

Authors: Ulrich Gerckens, George Latsios, Ralf Mueller, Lutz Buellesfeld, Barthel Sauren, Stein Iversen, Thomas Felderhof, Eberhard Grube

Published in: Clinical Research in Cardiology | Issue 10/2009

Login to get access

Excerpt

Open heart surgery with valve replacement is the current gold-standard therapeutic approach for severe aortic valve disease. However, many patients are considered high-risk candidates or even inoperable due to age or other co-morbid conditions [1]. In the Euro Heart Survey, up to 33% of patients in NYHA functional class III–IV with aortic valve stenosis were not operated [2]. For these reasons, less invasive techniques for treatment of high risk patients have been developed. These procedures have been named trans-cutaneous aortic valve implantation (TAVI). …
Literature
1.
Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15(6):816–822PubMedCrossRef
2.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart survey on valvular heart disease. Eur Heart J 24(13):1231–1243PubMedCrossRef
3.
Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114(15):1616–1624 (Epub 2006 Oct 2)PubMedCrossRef
4.
Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50(1):69–76 (Epub 2007 Jun 6)PubMedCrossRef
5.
Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV (2007) Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116(7):755–763 (Epub 2007 Jul 23)PubMedCrossRef
6.
Bojara W, Mumme A, Gerckens U, Lindstaedt M, Gotzmann M, Germing A, Fritz M, Pennekamp W, Mügge A (2009) Implantation of the CoreValve self-expanding valve prosthesis via a subclavian artery approach: a case report. Clin Res Cardiol 98(3):201–204 (Epub 2009 Feb 13)PubMedCrossRef
7.
Buellesfeld L (2009) 12-month safety and performance results of transcatheter aortic valve implantation using the 18F CoreValve revalving prosthesis, Data presented during the EuroPCR 2009 congress, May 2009, Barcelona
8.
Laborde JC Axillary/subclavian access with transcatheter aortic valve implantation: a new and promising approach. On behalf of PAVR Registry Participants. Data presented during the EuroPCR 2009 congress, May 2009, Barcelona
Metadata
Title
Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication
Authors
Ulrich Gerckens
George Latsios
Ralf Mueller
Lutz Buellesfeld
Barthel Sauren
Stein Iversen
Thomas Felderhof
Eberhard Grube
Publication date
01-10-2009
Publisher
D. Steinkopff-Verlag
Published in
Clinical Research in Cardiology / Issue 10/2009
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-009-0062-9

Other articles of this Issue 10/2009

Clinical Research in Cardiology 10/2009 Go to the issue

Clinical Correspondence

Lost central venous line caused tricuspid stenosis after 28 years

Original Paper

Comparison of hospital-based versus home-based exercise training in patients with heart failure: effects on functional capacity, quality of life, psychological symptoms, and hemodynamic parameters

Original Paper

Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall study

Clinical Correspondence

Effects of selective If-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy

Original Paper

Endovascular reconstruction of the aortic bifurcation in patients with Leriche syndrome

Original Paper

Renal dysfunction is associated with shorter telomere length in heart failure